GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
2.880
-0.110 (-3.68%)
Jun 20, 2024, 2:53 PM EDT - Market open

GT Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2015
Net Income
-7.6-20.88-58.01-28.3-38.65
Upgrade
Depreciation & Amortization
00000
Upgrade
Share-Based Compensation
2.27.6533.930.275.31
Upgrade
Other Operating Activities
-3.46-1.988.4820.7729.68
Upgrade
Operating Cash Flow
-8.85-15.22-15.61-7.26-3.66
Upgrade
Capital Expenditures
00000.2
Upgrade
Change in Investments
-2.0112.15-23.0400
Upgrade
Investing Cash Flow
-2.0112.15-23.0400.2
Upgrade
Share Issuance / Repurchase
6.27041.1100
Upgrade
Debt Issued / Paid
001.2112.533.43
Upgrade
Other Financing Activities
--0.22---
Upgrade
Financing Cash Flow
6.27-0.2242.3212.533.43
Upgrade
Net Cash Flow
-4.59-3.33.675.27-0.03
Upgrade
Free Cash Flow
-8.85-15.22-15.61-7.26-3.46
Upgrade
Free Cash Flow Per Share
-6.57-14.32-16.63-49.68-30.66
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).